Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) Stock

Name: AEMD (Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist) first-party financial data
Creator: Signals.AI

Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) is a Healthcare stock trading at $1.92 (as of 2026-06-18), with a market capitalization of $1.55M and a trailing P/E of -0.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Insufficient source information was provided to describe the company’s business. The only available secondary text relates to Aethlon Medical, Inc., and it does not contain details about “Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD)” or any Signals.AI filings.

Valuation — source: SEC EDGAR (first-party)
Price	$1.92
Market Cap	$1.55M
P/E Ratio	-0.2
EV / EBITDA	0.0
Price / Book	0.98
Price / Sales	30.59
DCF Value (model)	$-48.12
DCF Upside vs Price	-2606.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$156534.00
Net Margin	-4568.6%
Return on Equity	-146.4%
Current Ratio	3.85
Revenue Growth (YoY)	-47.5%
EPS Growth (YoY)	23.7%
FCF Growth (YoY)	-8.4%

Financial Health — source: SEC EDGAR
Altman Z-Score	-39.82 (distress)

Valuation vs Sector & Industry
Stock P/E	-0.2
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-100.9%
vs Industry	-100.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock Fund Advisors ($75000.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	James Frakes
Employees	14
Country	US
IPO Date	1999-03-04

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.